Allakos Revenue and Competitors

Location

$162.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Allakos's estimated annual revenue is currently $6.5M per year.(i)
  • Allakos received $100.0M in venture funding in December 2017.
  • Allakos's estimated revenue per employee is $48,947
  • Allakos's total funding is $162.4M.
  • Allakos's current valuation is $415M. (January 2022)

Employee Data

  • Allakos has 133 Employees.(i)
  • Allakos grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power

$162.4M

Total Funding

133

Number of Employees

$6.5M

Revenue (est)

2%

Employee Growth %

$415M

Valuation

N/A

Accelerator

Allakos News

2022-04-20 - ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

(b) On April 15, 2022 , Mark Asbury informed Allakos Inc. (the "Company") of his decision to retire from his position as Chief Legal Officer and...

2022-04-20 - Ambys Medicines Expands Leadership Team with Key ...

Before Allakos, John held financial planning and analytics positions at Jaguar Health, BioMarin Pharmaceuticals, and Avinger, Inc. Earlier in...

2022-04-13 - Analysts Anticipate Allakos Inc. (NASDAQ:ALLK) to Announce ...

Allakos logo Equities analysts forecast that Allakos Inc. (NASDAQ:ALLK – Get Rating) will announce earnings of ($1.71) per share for the...

2019-09-08 - SG Americas Securities LLC Acquires 1,040 Shares of Allakos Inc (NASDAQ:ALLK)

SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.9M1350%$81M
#2
$34.4M1379%$23M
#3
$24.7M137N/AN/A
#4
$21.1M140-8%$103.6M
#5
$39.1M142-2%N/A

Allakos Funding

DateAmountRoundLead InvestorsReference
2014-10-01$10.0MUndisclosedMultipleArticle
2017-12-14$100.0MANew Enterprise AssociatesArticle